Health
Secondary antibiotic prophylaxis for latent rheumatic heart disease – MD Linx
MDLinx original journal summary on Rheumatic Fever, Cardiology from New England Journal of Medicine
In this study, secondary antibiotic prophylaxis administered to children and adolescents 5 to 17 years of age with latent rheumatic heart disease was shown to cause a reduction in the risk of disease progression at 2 years.
Continue Reading